Literature DB >> 30792243

Differential Inhibition of Neuronal Sodium Channel Subtypes by the General Anesthetic Isoflurane.

Cheng Zhou1, Kenneth W Johnson1, Karl F Herold1, Hugh C Hemmings2.   

Abstract

Volatile anesthetics depress neurotransmitter release in a brain region- and neurotransmitter-selective manner by unclear mechanisms. Voltage-gated sodium channels (Navs), which are coupled to synaptic vesicle exocytosis, are inhibited by volatile anesthetics through reduction of peak current and modulation of gating. Subtype-selective effects of anesthetics on Nav might contribute to observed neurotransmitter-selective anesthetic effects on release. We analyzed anesthetic effects on Na+ currents mediated by the principal neuronal Nav subtypes Nav1.1, Nav1.2, and Nav1.6 heterologously expressed in ND7/23 neuroblastoma cells using whole-cell patch-clamp electrophysiology. Isoflurane at clinically relevant concentrations induced a hyperpolarizing shift in the voltage dependence of steady-state inactivation and slowed recovery from fast inactivation in all three Nav subtypes, with the voltage of half-maximal steady-state inactivation significantly more positive for Nav1.1 (-49.7 ± 3.9 mV) than for Nav1.2 (-57.5 ± 1.2 mV) or Nav1.6 (-58.0 ± 3.8 mV). Isoflurane significantly inhibited peak Na+ current (I Na) in a voltage-dependent manner: at a physiologically relevant holding potential of -70 mV, isoflurane inhibited peak I Na of Nav1.2 (16.5% ± 5.5%) and Nav1.6 (18.0% ± 7.8%), but not of Nav1.1 (1.2% ± 0.8%). Since Nav subtypes are differentially expressed both between neuronal types and within neurons, greater inhibition of Nav1.2 and Nav1.6 compared with Nav1.1 could contribute to neurotransmitter-selective effects of isoflurane on synaptic transmission.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30792243      PMCID: PMC6439525          DOI: 10.1124/jpet.118.254938

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  71 in total

1.  Comparative distribution of voltage-gated sodium channel proteins in human brain.

Authors:  W R Whitaker; R L Faull; H J Waldvogel; C J Plumpton; P C Emson; J J Clare
Journal:  Brain Res Mol Brain Res       Date:  2001-03-31

2.  Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons.

Authors:  Raimund I Herzog; Theodore R Cummins; Farshid Ghassemi; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  J Physiol       Date:  2003-07-03       Impact factor: 5.182

3.  What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs?

Authors:  S Taheri; M J Halsey; J Liu; E I Eger; D D Koblin; M J Laster
Journal:  Anesth Analg       Date:  1991-05       Impact factor: 5.108

Review 4.  Molecular targets underlying general anaesthesia.

Authors:  Nicholas P Franks
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 5.  The action potential in mammalian central neurons.

Authors:  Bruce P Bean
Journal:  Nat Rev Neurosci       Date:  2007-06       Impact factor: 34.870

6.  Volatile anesthetic effects on glutamate versus GABA release from isolated rat cortical nerve terminals: 4-aminopyridine-evoked release.

Authors:  Robert I Westphalen; Hugh C Hemmings
Journal:  J Pharmacol Exp Ther       Date:  2005-09-20       Impact factor: 4.030

7.  Temperature dependence of the sodium channel gating kinetics in the node of Ranvier.

Authors:  C A Collins; E Rojas
Journal:  Q J Exp Physiol       Date:  1982-01

8.  The effects of halothane and isoflurane on slowly inactivating sodium current in canine cardiac Purkinje cells.

Authors:  H Eskinder; F D Supan; L A Turner; J P Kampine; Z J Bosnjak
Journal:  Anesth Analg       Date:  1993-07       Impact factor: 5.108

9.  Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects.

Authors:  Sandrine Cestèle; Emanuele Schiavon; Raffaella Rusconi; Silvana Franceschetti; Massimo Mantegazza
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

10.  Molecular identity of axonal sodium channels in human cortical pyramidal cells.

Authors:  Cuiping Tian; Kaiyan Wang; Wei Ke; Hui Guo; Yousheng Shu
Journal:  Front Cell Neurosci       Date:  2014-09-23       Impact factor: 5.505

View more
  7 in total

1.  Selective inhibition of gamma aminobutyric acid release from mouse hippocampal interneurone subtypes by the volatile anaesthetic isoflurane.

Authors:  Iris A Speigel; Hugh C Hemmings
Journal:  Br J Anaesth       Date:  2021-08-10       Impact factor: 11.719

2.  The General Anesthetic Isoflurane Bilaterally Modulates Neuronal Excitability.

Authors:  Mengchan Ou; Wenling Zhao; Jin Liu; Peng Liang; Han Huang; Hai Yu; Tao Zhu; Cheng Zhou
Journal:  iScience       Date:  2019-12-10

Review 3.  The Effects of General Anesthetics on Synaptic Transmission.

Authors:  Xuechao Hao; Mengchan Ou; Donghang Zhang; Wenling Zhao; Yaoxin Yang; Jin Liu; Hui Yang; Tao Zhu; Yu Li; Cheng Zhou
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 4.  Relevance of Cortical and Hippocampal Interneuron Functional Diversity to General Anesthetic Mechanisms: A Narrative Review.

Authors:  Iris A Speigel; Hugh C Hemmings
Journal:  Front Synaptic Neurosci       Date:  2022-01-26

Review 5.  Effects of General Anesthetics on Synaptic Transmission and Plasticity.

Authors:  Jimcy Platholi; Hugh C Hemmings
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

6.  Proportional Downscaling of Glutamatergic Release Sites by the General Anesthetic Propofol at Drosophila Motor Nerve Terminals.

Authors:  Shanker Karunanithi; Drew Cylinder; Deniz Ertekin; Oressia H Zalucki; Leo Marin; Nickolas A Lavidis; Harold L Atwood; Bruno van Swinderen
Journal:  eNeuro       Date:  2020-02-28

7.  The T-type calcium channel isoform Cav3.1 is a target for the hypnotic effect of the anaesthetic neurosteroid (3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile.

Authors:  Tamara Timic Stamenic; Simon Feseha; Francesca M Manzella; Damon Wallace; Davis Wilkey; Timothy Corrigan; Hanna Fiedler; Patricia Doerr; Kathiresan Krishnan; Yogendra H Raol; Douglas F Covey; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  Br J Anaesth       Date:  2020-08-25       Impact factor: 9.166

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.